A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine
Condition(s):Human Papillomavirus InfectionLast Updated:January 4, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Human Papillomavirus InfectionLast Updated:January 4, 2023Active, not recruiting
Condition(s):Anal NeoplasmLast Updated:July 14, 2023Completed
Condition(s):Cervical Cancer; Head and Neck Cancer; Anal CancerLast Updated:December 8, 2022Terminated
Condition(s):Cervical Cancer; Anal Cancer; Head and Neck CancersLast Updated:June 28, 2022Recruiting
Condition(s):Squamous Cell Carcinoma of the Anal CanalLast Updated:December 13, 2023Active, not recruiting
Condition(s):Head and Neck Cancer; Ovarian Cancer; Cervical Cancer; Cervical Intraepithelial Neoplasia 3; Glioblastoma Multiforme of Brain Stem; Non Small Cell Lung Cancer; Anal CancerLast Updated:July 24, 2023Recruiting
Condition(s):Anal Cancer; Nonneoplastic Condition; Penile Cancer; Precancerous ConditionLast Updated:August 11, 2020Completed
Condition(s):Anus Neoplasms; HIV InfectionsLast Updated:May 1, 2019Completed
Condition(s):Human Papillomavirus Infection; HPV; HPV Infection; Anal Cancer; Cancer; Men; HPV 16 InfectionLast Updated:March 15, 2023Recruiting
Condition(s):Human Papillomavirus Infection; HPV; HPV Infection; Anal Cancer; Cancer; Men; HPV 16 InfectionLast Updated:March 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.